ArticleTheranostics2021

KDM6A promotes imatinib resistance through YY1-mediated transcriptional upregulation of TRKA independently of its demethylase activity in chronic myelogenous leukemia.

Chengwan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.